
The experts designed purpose-built preprocessing pipelines to ingest complex pharmaceutical PDFs, extracting and structuring drug information, then tuned a RAG architecture to the domain with semantic chunking and hybrid retrieval. To manage hallucination risk in a regulated setting, they embedded a proprietary Continuous Alignment Testing framework that monitored outputs at the developer, overnight, and production levels, keeping human specialists in the loop for final validation. The working drug-equivalency recommendation system was delivered in roughly 10 weeks.
The work combined RAG-based knowledge management and search with document processing and extraction, built on a custom/proprietary model on AWS. The RAG architecture used semantic chunking aligned to pharmaceutical data and hybrid retrieval, wrapped in a proprietary Continuous Alignment Testing (CAT) reliability framework.
The team delivered a working proof-of-concept-to-solution in 10 weeks, freed human specialists from upstream manual data processing so they could focus on validation and high-judgment decisions, and used the CAT framework to hold the system to the ~95%+ accuracy needed for confident beta rollout in a high-stakes healthcare context.
Approximately 10 weeks of hands-on development — within the two-to-four-month range — compressing what had been projected as a multi-year initiative into a single quarter.
Fortune 500 enterprises and growth-stage companies (Series A and up) in highly regulated industries — especially healthcare, financial services, and media — that need custom AI-native software, fast movement from POC to production, and reliability frameworks for non-deterministic AI outputs.